Found 5 matching trials
Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors
PHASE1RATINALE: Placing a tumor antigen chimeric receptor that has been created i...
Location
Chinese PLA General Hospital
Combination Immunotherapy Targeting Sarcomas
PHASE1The aim of this clinical trial is to assess the feasibility, safety and eff...
Location
Shenzhen Geno-Immune Medical Institute
Multi-4SCAR-T Therapy Targeting Breast Cancer
PHASE1The purpose of this study is to assess the feasibility, safety and efficacy...
Location
Shenzhen Geno-immuno Medical Institute
A Study of CART-TnMUC1 in Patients With TnMUC1-Positive Advanced Cancers
PHASE1Multi-center, open-label, first in human Phase 1 study of the safety, toler...
Location
Mayo Clinic of Arizona
A Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor T-cell (CART) in the Treatment of Solid Tumors
NAThis is a single-arm, investigator-initiated exploratory study.The study is...
Location
Multiple Locations